Generated by AI
Anika Therapeutics Inc. is a medical technology company focused on joint preservation and early intervention orthopedics. The company develops, manufactures, and commercializes hyaluronic acid-based products used in osteoarthritis pain management, regenerative medicine, sports medicine, and soft tissue repair. Its portfolio includes injectable therapies and orthopedic solutions designed to support mobility, tissue healing, and minimally invasive care for patients with degenerative joint conditions and musculoskeletal injuries. Anika Therapeutics serves healthcare professionals and clinical settings across the United States, Europe, and other international markets, with products used in orthopedics and related surgical applications. Headquartered in Bedford, Massachusetts, Anika Therapeutics Inc. plays a specialized role in the musculoskeletal care market by offering therapies and biomaterials that address joint health, cartilage repair, and recovery support.
Website32 Wiggins Avenue
Bedford, MA, 01730
United States
The latest articles about ANIK.
Anika Therapeutics Inc (ANIK) posted 10% revenue growth and record commercial channel sales in Q3 2026, but lowered commercial guidance and faces FDA setbacks on its Hyalafast PMA.
Motley Fool Press Release.
Summary of Jul 30's posts. Generated by AI.
No summary yet.
Summary of Oct 25's posts. Generated by AI.
Summary of Feb 26's posts. Generated by AI.
Summary of Jul 25's posts. Generated by AI.
Investors talking about ANIK also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.